| Dr Gretchen Randolph, PHD, PMHNP | |
|
13635 Sw 115th Ave, Tigard, OR 97223-2862 | |
| (503) 968-1155 | |
| Not Available |
| Full Name | Dr Gretchen Randolph |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 13635 Sw 115th Ave, Tigard, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184876898 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | S80045119NG (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gretchen Randolph, PHD, PMHNP 13635 Sw 115th Ave, Tigard, OR 97223-2862 Ph: (503) 968-1155 | Dr Gretchen Randolph, PHD, PMHNP 13635 Sw 115th Ave, Tigard, OR 97223-2862 Ph: (503) 968-1155 |
News Archive
The news about the novel coronavirus in China grows more urgent daily. The number of related deaths is now greater than 1,300, while tens of thousands of people have been infected — most of them in China. People returning to the U.S. from China are quarantined for 14 days.
Novel nanomaterials derived from cellulose have many promising industrial applications, are biobased and biodegradable, and can be produced at relatively low cost. Their potential toxicity-whether ingested, inhaled, on contact with the skin, or on exposure to cells within the body-is a topic of intense discussion, and the latest evidence and insights on cellulose nanocrystal toxicity are presented in a Review article in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Across the country, states reported computer problems and long wait times as consumers tried to check out the new insurance options available through the health law's online insurance marketplaces. At the same time, though, many states reported tallies of applications and hits that exceeded expectations.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Gynecologic Oncology Group (GOG) will initiate a Phase 2 clinical trial of elesclomol in combination with paclitaxel for the treatment of persistent or recurrent ovarian, fallopian tube or primary peritoneal cancer.
› Verified 1 days ago
Joseph Roy Zelk, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 10220 Sw Greenburg Rd., Suite 150, Tigard, OR 97223 Phone: 503-255-1200 Fax: 503-408-6856 | |
Kecia Harris, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 11481 Sw Hall Blvd Ste 200, Tigard, OR 97223 Phone: 503-980-4334 | |
Mrs. Luiza Maria Brown, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7632 Sw Durham Rd Ste 130, Tigard, OR 97224 Phone: 800-936-4756 | |
Martina D Ford, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9370 Sw Greenburg Rd Ste 200, Tigard, OR 97223 Phone: 877-448-3627 | |
Martha Patrice Geisheker, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12442 Sw Scholls Ferry Rd Ste 100, Tigard, OR 97223 Phone: 503-216-9200 | |
Alexandria Raene Thacker, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 12115 Sw 70th Ave Ste 202, Tigard, OR 97223 Phone: 503-404-2338 |